Abstract
Post-translational modifications are necessary for collagen precursor molecules (procollagens) to acquire final shape and function. However, the mechanism and contribution of collagen modifications that occur outside the endoplasmic reticulum and Golgi are not understood. We discovered that VIPAR, with its partner proteins, regulate sorting of lysyl hydroxylase 3 (LH3, also known as PLOD3) into newly identified post-Golgi collagen IV carriers and that VIPAR-dependent sorting is essential for modification of lysines in multiple collagen types. Identification of structural and functional collagen abnormalities in cells and tissues from patients and murine models of the autosomal recessive multisystem disorder Arthrogryposis, Renal dysfunction and Cholestasis syndrome caused by VIPAR and VPS33B deficiencies confirmed our findings. Thus, regulation of post-Golgi LH3 trafficking is essential for collagen homeostasis and for the development and function of multiple organs and tissues.
Introduction
Collagen is the most abundant protein in the human body, serving as the primary structural scaffold for connective tissues. Its functional integrity relies on extensive post-translational modifications (PTMs), such as the hydroxylation and glycosylation of lysine residues. While it is well-established that most PTMs occur within the Endoplasmic Reticulum (ER) and Golgi apparatus, the enzyme Lysyl Hydroxylase 3 (LH3) is known to function in post-Golgi compartments. The mechanism governing LH3's post-Golgi trafficking and its physiological significance have remained elusive until now.
The VIPAR-VPS33B-LH3 Sorting Mechanism
Through a combination of proteomics and biochemical assays, researchers identified LH3 as a novel interactor with the VIPAR-VPS33B complex. VIPAR acts as a molecular bridge: its N-terminus binds to LH3, while its C-terminus anchors to VPS33B. This interaction is critical for the proper sorting of LH3. In cells deficient in VIPAR or VPS33B, LH3 fails to reach its intended destination and is instead diverted to lysosomes for degradation.
Discovery of Collagen IV Carriers (CIVCs)
Advanced imaging, including Correlative Light and Electron Microscopy (CLEM), revealed the existence of a previously unknown organelle: the Collagen IV Carrier (CIVC). These large (200–900 nm) post-Golgi vesicles are responsible for the co-transport of Collagen IV and LH3. The presence of LH3 within these carriers suggests that collagen modification continues actively during transport to the cell surface, a process regulated by a sequential Rab "relay" involving RAB10 and RAB25.
Clinical Relevance: ARC Syndrome as a Collagen Disorder
Arthrogryposis, Renal dysfunction, and Cholestasis (ARC) syndrome is a severe multisystem disorder caused by mutations in VIPAR or VPS33B. This research redefines ARC syndrome as a disorder of collagen homeostasis. Mass spectrometry of patient samples and VIPAR-deficient cells showed a significant reduction in LH3-specific collagen modifications. Furthermore, structural analysis using Atomic Force Microscopy (AFM) of mouse models demonstrated "swollen and distorted" collagen fibrils, providing a molecular explanation for the connective tissue defects and bone fragility seen in ARC patients.
Conclusion and Future Directions
This study identifies a critical post-Golgi trafficking pathway essential for collagen maturation and tissue homeostasis. The VIPAR-VPS33B complex's role in sorting LH3 into CIVCs represents a novel regulatory step in collagen biosynthesis. Future research will focus on identifying the transmembrane "intermediate mediator" that connects the cytoplasmic VIPAR-VPS33B complex to the luminal LH3 enzyme, as well as determining if CIVCs are universal carriers for all secreted collagen types.
Summary updated